Topical Finasteride: The Alternative to the Pill
Topical finasteride delivers DHT suppression directly to the scalp with significantly less systemic absorption than oral finasteride, making it an important option for men concerned about systemic hormonal effects.
systemic DHT reduction with topical finasteride vs ~70% with oral, key advantage for side effect-sensitive users
, Caserini et al., 2018
scalp DHT suppression and hair density improvements vs oral finasteride in head-to-head studies
year the first FDA-approved topical combination (finasteride + minoxidil spray) was authorized for men with AGA
Why Choose Topical Over Oral?
The primary appeal is a more localized effect, the same scalp DHT suppression with less systemic hormonal impact.
Reduced Systemic Exposure
Topical application delivers finasteride primarily to the scalp. Systemic absorption is real but significantly lower than oral, resulting in less suppression of DHT throughout the body, potentially preserving testosterone-related functions.
Scalp-Targeted DHT Suppression
Studies show scalp DHT is reduced by 50–70% with topical finasteride, similar to oral in the target tissue that matters most for hair loss. The drug reaches the follicle where it's needed.
Combination Formulas Available
Topical finasteride is increasingly available in combination with topical minoxidil in a single daily application. This provides dual-mechanism treatment (DHT blocking + follicle stimulation) with one product.
Option for Side-Effect Sensitive Patients
For men who have discontinued oral finasteride due to side effects, or who are concerned about systemic hormonal effects, topical provides a path to DHT inhibition with potentially better tolerability.
Topical vs Oral Finasteride: Side-by-Side
Neither is strictly better, the right choice depends on your priorities and risk tolerance.
Important Considerations
Topical finasteride has real advantages, but it's not without nuances worth understanding before starting.
Scalp absorption varies
The scalp has variable blood supply and skin thickness. Absorption can differ between individuals and even scalp regions, making standardized dosing imprecise compared to oral.
Risk of partner exposure
Topical finasteride on the scalp can transfer to partners through contact. Women who are or may become pregnant must avoid contact with the treated scalp, finasteride can harm male fetal genital development.
Compounding quality varies
Most topical finasteride is made by compounding pharmacies, where potency, sterility, and formulation quality can vary between providers. Use accredited compounding pharmacies.
Long-term data still emerging
Oral finasteride has 25+ years of post-market safety data. Topical formulations are relatively newer, and 10–20 year safety outcomes are not yet available.
Important: Like oral finasteride, topical finasteride must not be handled by pregnant women or women of childbearing potential. Even topical exposure can pose risks. Store safely and ensure partner safety.
Who Is Topical Finasteride Best For?
Good candidates
- Men who stopped oral finasteride due to sexual side effects
- Men who want DHT suppression but prefer lower systemic exposure
- Men who want combination topical therapy (finasteride + minoxidil in one)
- Younger men concerned about long-term hormonal effects
Less suitable for
- Women (particularly those who are pregnant or may become pregnant)
- Patients who want the most extensively studied option (oral has 25+ years of data)
- Those looking for lowest cost option (oral generic is cheaper)
- Patients who find daily scalp application inconvenient
Track Your Treatment Response
Whether topical or oral, knowing if finasteride is actually working requires consistent, objective monitoring. Trichometrics' AI photo analysis tracks your scalp density over time so you can quantify your response.
Start Tracking FreeFrequently Asked Questions
Does topical finasteride work as well as oral finasteride?▾
Evidence suggests topical finasteride is effective, with several studies showing comparable hair density improvements to oral finasteride at standard doses. A key 2018 trial (Caserini et al.) found topical finasteride 0.25% once daily produced similar scalp DHT suppression to oral 1mg with significantly lower systemic DHT reduction (~30% vs ~70% for oral), meaning similar efficacy with less systemic hormonal impact. Head-to-head comparison data is still accumulating, but topical is increasingly considered a legitimate alternative rather than a compromise.
Does topical finasteride cause sexual side effects?▾
This is the primary reason patients seek topical finasteride, to minimize the sexual side effects (reduced libido, erectile dysfunction, ejaculatory changes) associated with oral finasteride at a low but real rate (~2–3% in clinical trials). Because topical application results in far lower systemic DHT suppression (~30% vs ~70%), the risk of systemic side effects is theoretically lower. Published studies have not shown significant sexual side effects at topical doses. However, as a newer formulation with less long-term data than oral, the risk is not zero, and individual responses vary.
How is topical finasteride applied?▾
Topical finasteride is applied directly to the scalp (not rinsed out), typically once daily. It is usually compounded or provided as a solution/spray at concentrations between 0.1%–0.25%. Some formulations combine topical finasteride with topical minoxidil in a single solution for convenience. Application to the affected scalp area (temples, crown) with fingers or a dropper is standard. Hands should be washed thoroughly after application to avoid accidental transfer.
Is topical finasteride FDA-approved?▾
Not currently. As of 2026, topical finasteride is not FDA-approved for hair loss, unlike oral finasteride (Propecia, 1mg) which was approved in 1997. Topical formulations are typically obtained through compounding pharmacies with a prescription, or through some direct-to-consumer hair loss companies. Lifelight's spray (finasteride 0.25% + minoxidil 6%) received FDA approval in 2022 for androgenetic alopecia in men, making it the first approved combination topical. Regulatory status continues to evolve.